Inhibition of proliferation and induction of G₁-phase cell-cycle arrest by dFMGEN, a novel genistein derivative, in lung carcinoma A549 cells

References

• Aminimoghadamfarouj, N., Nematollahi, A., Wiart, C. (2011). Annonaceae: bio-resource for tomorrow’s drug discovery. J Asian Nat Prod Res 13:465–476.
   PubMed Web of Science ®Google Scholar
• Bible, K. C., Kaufmann, S. H. (1996). Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells. Cancer Res 56:4856–4861.
   PubMed Web of Science ®Google Scholar
• Chang, G. C., Hsu, S. L., Tsai, J. R., Liang, F. P., Lin, S. Y., Sheu, G. T., et al. (2004). Molecular mechanisms of ZD1839-induced G1-cell cycle arrest and apoptosis in human lung adenocarcinoma A549 cells. Biochem Pharmacol 68:1453–1464.
   PubMed Web of Science ®Google Scholar
• Chen, J., Lin, H., Hu, M. (2005). Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model. Cancer Chemother Pharmacol 55:159–169.
   PubMed Web of Science ®Google Scholar
• Ferreira, S. B., Costa, M. S., Boechat, N., Bezerra, R. J., Genestra, M. S., Canto-Cavalheiro, M. M., et al. (2007). Synthesis and evaluation of new difluoromethyl azoles as antileishmanial agents. Eur J Med Chem 42:1388–1395.
   PubMed Web of Science ®Google Scholar
• Fu, X. H., Wang, L., Zhao, H., Xiang, H. L., Cao, J. G. (2008). Synthesis of genistein derivatives and determination of their protective effects against vascular endothelial cell damages caused by hydrogen peroxide. Bioorg Med Chem Lett 18:513–517.
   PubMed Web of Science ®Google Scholar
• Guo, R., Cao, Y. Y., Dai, Z. Z., Zhuang, J. Y. (1981). [Characteristics of a human diploid cell line, KMB-17]. [Article in Chinese]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 3:226–230.
   PubMedGoogle Scholar
• Haddadin, S., Perry, M. C. (2011). History of small-cell lung cancer. Clin Lung Cancer 12:87–93.
   PubMed Web of Science ®Google Scholar
• Johnson, N., Shapiro, G. I. (2010). Cyclin-dependent kinases (cdks) and the DNA damage response: rationale for cdk inhibitor-chemotherapy combinations as an anticancer strategy for solid tumors. Expert Opin Ther Targets 14:1199–1212.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., Bartek, J. (2004). Cell-cycle checkpoints and cancer. Nature 432:316–323.
   PubMed Web of Science ®Google Scholar
• Kataoka, K., Suzuki, R., Taniguchi, H., Noda, Y., Shindoh, J., Matsumoto, S., et al. (2006). Phase I/II trial of docetaxel and carboplatin as a first-line therapy in patients with stage IV non-small-cell lung cancer. Lung 184:133–139.
   PubMed Web of Science ®Google Scholar
• Krystof, V., Uldrijan, S. (2010). Cyclin-dependent kinase inhibitors as anticancer drugs. Curr Drug Targets 11:291–302.
   PubMed Web of Science ®Google Scholar
• Kwon, S. H., Kim, S. Y., Ha, K. W., Kang, M. J., Huh, J. S., Im, T. J., et al. (2007). Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery. Arch Pharm Res 30:1138–1143.
   PubMed Web of Science ®Google Scholar
• Li, M., Zhang, Z., Hill, D. L., Chen, X., Wang, H., Zhang, R. (2005). Genistein, a dietary isoflavone, down-regulates the MDM2 oncogene at both transcriptional and posttranslational levels. Cancer Res 65:8200–8208.
   PubMed Web of Science ®Google Scholar
• Lu, X., Jung, J., Cho, H. J., Lim, D. Y., Lee, H. S., Chun, H. S., et al. (2005). Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells. J Nutr 135:2884–2890.
   PubMed Web of Science ®Google Scholar
• Paulo, A., Mota-Filipe, H. (2006). Effects of some natural 5-hydroxy-isoflavones on cultured human endothelial cells in presence and absence of hydrogen peroxide. J Pharm Pharmacol 58:101–105.
   PubMed Web of Science ®Google Scholar
• Proskuryakov, S. Y., Konoplyannikov, A. G., Gabai, V. L. (2003). Necrosis: a specific form of programmed cell death? Exp Cell Res 283:1–16.
   PubMed Web of Science ®Google Scholar
• Raez, L. E., Lilenbaum, R. (2006). New developments in chemotherapy for advanced non-small cell lung cancer. Curr Opin Oncol 18:156–161.
   PubMed Web of Science ®Google Scholar
• Ravindranath, M. H., Muthugounder, S., Presser, N., Viswanathan, S. (2004). Anticancer therapeutic potential of soy isoflavone, genistein. Adv Exp Med Biol 546:121–165.
   PubMed Web of Science ®Google Scholar
• Rowland, I., Faughnan, M., Hoey, L., Wahala, K., Williamson, G., Cassidy, A. (2003). Bioavailability of phyto-oestrogens. Br J Nutr 89(Suppl 1):S45–S58.
   PubMedGoogle Scholar
• Santell, R. C., Kieu, N., Helferich, W. G. (2000). Genistein inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice. J Nutr 130:1665–1669.
   PubMed Web of Science ®Google Scholar
• Shah, M. A., Schwartz, G. K. (2001). Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin Cancer Res 7:2168–2181.
   PubMed Web of Science ®Google Scholar
• Shanmugam, M. K., Kannaiyan, R., Sethi, G. (2011). Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer 63:161–173.
   PubMed Web of Science ®Google Scholar
• Shon, Y. H., Park, S. D., Nam, K. S. (2006). Effective chemopreventive activity of genistein against human breast cancer cells. J Biochem Mol Biol 39:448–451.
   PubMedGoogle Scholar
• Swanton, C. (2004). Cell-cycle targeted therapies. Lancet Oncol 5:27–36.
   PubMed Web of Science ®Google Scholar
• Wachsberger, P. R., Burd, R., Marero, N., Daskalakis, C., Ryan, A., McCue, P., et al. (2005). Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma. Clin Cancer Res 11:835–842.
   PubMed Web of Science ®Google Scholar
• Wang, J., Shang, F., Jiang, R., Liu, L., Wang, S., Hou, J., et al. (2007). Nitric oxide-donating genistein prodrug: design, synthesis, and bioactivity on MC3T3-E1 cells. J Pharmacol Sci 104:82–89.
   PubMed Web of Science ®Google Scholar
• Wang, L., Zheng, X., Xiang, H. L., Fu, X. H., Cao, J. G. (2009). 7-Difluoromethyl-5,4′-dimethoxygenistein inhibits oxidative stress induced adhesion between endothelial cells and monocytes via NF-kappaB. Eur J Pharmacol 605:31–35.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Li, X. L., Yao, X. S., Wong, M. S. (2008). Osteogenic activities of genistein derivatives were influenced by the presence of prenyl group at ring A. Arch Pharm Res 31:1534–1539.
   PubMed Web of Science ®Google Scholar
• Zhao, H., Li, C., Cao, J. G., Xiang, H. L., Yang, H. Z., You, J. L., et al. (2009). 7-Difluoromethyl-5,4′-dimethoxygenistein, a novel genistein derivative, has therapeutic effects on atherosclerosis in a rabbit model. J Cardiovasc Pharmacol 54:412–420.
   PubMed Web of Science ®Google Scholar